Search

everythinglearnresearchcommunity

for

Search:↓

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Erlotinib can cause hair loss as a side effect.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Ruxolitinib cream may help treat severe hair loss in children.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

The committee decided not to approve the drug due to low effectiveness and high risks.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

ITK inhibitors may effectively treat alopecia areata.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.